These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36271650)

  • 1. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.
    Kotton CN; Torre-Cisneros J; ; Aguado JM; Alain S; Baldanti F; Baumann G; Boeken U; de la Calle M; Carbone J; Ciceri F; Comoli P; Couzi L; Danziger-Isakov L; Fernández-Ruiz M; Girmenia C; Grossi PA; Hirsch HH; Humar A; Kamar N; Kotton C; Ljungman P; Malagola M; Mira E; Mueller N; Sester M; Teng CJ; Torre-Cisneros J; Ussetti P; Westall G; Wolf D; Zamora M
    Transpl Infect Dis; 2022 Dec; 24(6):e13977. PubMed ID: 36271650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slaying the "Troll of Transplantation"-new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023.
    Kotton CN; Torre-Cisneros J; Yakoub-Agha I;
    Transpl Infect Dis; 2024 Feb; 26(1):e14183. PubMed ID: 37942955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.
    Girmenia C; Lazzarotto T; Bonifazi F; Patriarca F; Irrera G; Ciceri F; Aversa F; Citterio F; Cillo U; Cozzi E; Gringeri E; Baldanti F; Cavallo R; Clerici P; Barosi G; Grossi P
    Clin Transplant; 2019 Oct; 33(10):e13666. PubMed ID: 31310687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
    Haidar G; Boeckh M; Singh N
    J Infect Dis; 2020 Mar; 221(Suppl 1):S23-S31. PubMed ID: 32134486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
    Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
    Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
    Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
    Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cytomegalovirus infection in solid organ transplantation.
    Kotton CN
    Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
    Grossi P; Mohacsi P; Szabolcs Z; Potena L
    Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S1-4. PubMed ID: 26900989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
    Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
    Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
    Hebart H; Kanz L; Jahn G; Einsele H
    Drugs; 1998 Jan; 55(1):59-72. PubMed ID: 9463790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
    Razonable RR; Humar A
    Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ; Razonable RR
    Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.
    Sia IG; Patel R
    Clin Microbiol Rev; 2000 Jan; 13(1):83-121, table of contents. PubMed ID: 10627493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on the management of cytomegalovirus infection in transplant recipients].
    Neofytos D; Van Delden C; Manuel O
    Rev Med Suisse; 2023 Apr; 19(822):726-730. PubMed ID: 37057854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity.
    Manuel O; Avery RK
    Curr Opin Infect Dis; 2021 Aug; 34(4):307-313. PubMed ID: 34074879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.
    Ranganathan K; Worley S; Michaels MG; Arrigan S; Aurora P; Ballmann M; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Mallory GB; Mogayzel PJ; Parakininkas D; Solomon M; Visner G; Sweet SC; Faro A; Danziger-Isakov L
    J Heart Lung Transplant; 2009 Oct; 28(10):1050-6. PubMed ID: 19782286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.
    Meesing A; Razonable RR
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):773-788. PubMed ID: 30009675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Cell-mediated Immunity Assays in Pediatric Transplantation.
    Otto WR; Vora SB; Dulek DE
    J Pediatric Infect Dis Soc; 2024 Feb; 13(Supplement_1):S22-S30. PubMed ID: 38417088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions.
    Razonable RR
    Curr Pharm Des; 2020; 26(28):3497-3506. PubMed ID: 32473617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients.
    Saullo JL; Miller RA
    Annu Rev Med; 2023 Jan; 74():89-105. PubMed ID: 36332639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.